Dingdang Health reports 69.86 million-share buyback with no change in total issued shares

Bulletin Express05-26 18:44

Hong Kong—Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return on 26 May 2026 confirming that the company’s issued share capital remained unchanged at 1,319.47 million ordinary shares between 22 May and 26 May 2026.

Since the current repurchase mandate was approved on 28 May 2025, Dingdang Health has repurchased 69.86 million shares—equivalent to 5.29% of the issued share count on the mandate date—for a cumulative consideration of approximately HKD 70 million (based on disclosed daily purchase prices). All repurchased shares are held for cancellation and have not yet been cancelled.

The latest on-market transaction took place on 26 May 2026, when 136,500 shares were bought back at prices ranging from HKD 0.88 to HKD 0.90, costing HKD 0.12 million. Following this purchase, the company remains authorised to repurchase up to an additional 62.09 million shares under the existing mandate.

Under Hong Kong Listing Rule 10.06(3)(a), Dingdang Health is subject to a moratorium on new share issues or treasury-share sales until 25 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1195622694?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 18:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195622694","market":"hk","top_or_hot":-1,"title":"Dingdang Health reports 69.86 million-share buyback with no change in total issued shares","media":"Bulletin Express","content":"<p>Hong Kong—Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return on 26 May 2026 confirming that the company’s issued share capital remained unchanged at 1,319.47 million ordinary shares between 22 May and 26 May 2026.</p>\n<p>Since the current repurchase mandate was approved on 28 May 2025, Dingdang Health has repurchased 69.86 million shares—equivalent to 5.29% of the issued share count on the mandate date—for a cumulative consideration of approximately HKD 70 million (based on disclosed daily purchase prices). All repurchased shares are held for cancellation and have not yet been cancelled.</p>\n<p>The latest on-market transaction took place on 26 May 2026, when 136,500 shares were bought back at prices ranging from HKD 0.88 to HKD 0.90, costing HKD 0.12 million. Following this purchase, the company remains authorised to repurchase up to an additional 62.09 million shares under the existing mandate.</p>\n<p>Under Hong Kong Listing Rule 10.06(3)(a), Dingdang Health is subject to a moratorium on new share issues or treasury-share sales until 25 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health reports 69.86 million-share buyback with no change in total issued shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health reports 69.86 million-share buyback with no change in total issued shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-26 18:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong—Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return on 26 May 2026 confirming that the company’s issued share capital remained unchanged at 1,319.47 million ordinary shares between 22 May and 26 May 2026.</p>\n<p>Since the current repurchase mandate was approved on 28 May 2025, Dingdang Health has repurchased 69.86 million shares—equivalent to 5.29% of the issued share count on the mandate date—for a cumulative consideration of approximately HKD 70 million (based on disclosed daily purchase prices). All repurchased shares are held for cancellation and have not yet been cancelled.</p>\n<p>The latest on-market transaction took place on 26 May 2026, when 136,500 shares were bought back at prices ranging from HKD 0.88 to HKD 0.90, costing HKD 0.12 million. Following this purchase, the company remains authorised to repurchase up to an additional 62.09 million shares under the existing mandate.</p>\n<p>Under Hong Kong Listing Rule 10.06(3)(a), Dingdang Health is subject to a moratorium on new share issues or treasury-share sales until 25 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1195622694","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195622694","pubTimestamp":1779792265,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong—Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return on 26 May 2026 confirming that the company’s issued share capital remained unchanged at 1,319.47 million ordinary...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康报告回购6986万股，已发行股份总数没有变化","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Hong Kong—Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return on 26 May 2026 confirming that the company’s issued share capital remained unchanged at 1,319.47 million ordinary shares between 22 May and 26 May 2026.\nSince the current repurchase mandate was approved on 28 May 2025, Dingdang Health has repurchased 69.86 million shares—equivalent to 5.29% of the issued share count on the mandate date—for a cumulative consideration of approximately HKD 70 million (based on disclosed daily purchase prices). All repurchased shares are held for cancellation and have not yet been cancelled.\nThe latest on-market transaction took place on 26 May 2026, when 136,500 shares were bought back at prices ranging from HKD 0.88 to HKD 0.90, costing HKD 0.12 million. Following this purchase, the company remains authorised to repurchase up to an additional 62.09 million shares under the existing mandate.\nUnder Hong Kong Listing Rule 10.06(3)(a), Dingdang Health is subject to a moratorium on new share issues or treasury-share sales until 25 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1195622694","isCrawlerRequest":true}